MASIT (MAinz Seminars In Translational science): "Druggable Gene Editing Tools for Treating β-Thalassemia and Sickle Cell Disease" (Afsar Mian)

At the upcoming MASIT Seminar Dr. Afsar Mian ,Centre for Regenerative Medicine (CRM) Aga Khan University (AKU)Karachi, Pakistan, will hold a talk titled:
 
“Druggable Gene Editing Tools for Treating β-Thalassemia and Sickle Cell Disease”
 

Dr Afsar Mian is an Associate Professor and Group Leader at Aga Khan University’s Centre for Regenerative Medicine in Karachi, Pakistan. With nearly 20 years of translational research experience and a PhD from Goethe University Frankfurt, he develops therapies for hematological and inherited disorders using genome editing, stem cells, mRNA therapeutics, and CAR T-cell technologies. His contributions include the development of Vamotinib and Vodobatinib. He has secured major funding from Wellcome Leap and the HEC/World Bank Grand Challenge Fund and built international collaborations. His work combines advancing precision medicine with mentoring the next generation of scientists.

MS-Teams link
 
Meeting-ID: 323 681 674 970 25
Passcode: EC3CT3Fn

To get more information about Dr. Mian’s research, visit the following website: Afsar Mian | Centre for Regenerative Medicine and Stem Cell Research | The Aga Khan University 
And take a look at his publication list: Afsar Ali Mian AKU - Search Results - PubMed